Podcast 214: Drug-drug interactions and bleeding risks with NOACs

The non-vitamin-K oral anticoagulants (known familiarly as NOACs or DOACs) share metabolic pathways with other drugs, which can potentiate NOACs’ anticoagulant actions dangerously. Dr. Shang-Hung Chang and his group studied Taiwan’s national health insurance database, which records data on virtually all that nation’s citizens, to measure the actual risks of some of these drug – drug interactions. Their findings were published earlier this month in JAMA.

Links:

JAMA article (abstract)

Physician’s First Watch coverage

The post Podcast 214: Drug-drug interactions and bleeding risks with NOACs first appeared on Clinical Conversations.